C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease

被引:28
作者
Rerkasem, K
Shearman, CP
Williams, JA
Morris, GE
Phillips, MJ
Calder, PC
Grimble, RF
机构
[1] Southampton Gen Hosp, Dept Vasc Surg, Southampton SO16 6YD, Hants, England
[2] Univ Southampton, Inst Human Nutr, Southampton SO9 5NH, Hants, England
关键词
C-reactive protein; carotid endarterectomy; atherosclerosis; carotid stenosis;
D O I
10.1053/ejvs.2002.1632
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives: to investigate the level of inflammatory markers between symptomatic and asymptomatic carotid stenosis patients. Design: cross-sectional study Materials and methods: a prospective study of 137 consecutive patients, admitted electively for carotid endarterectomy during 1997-2000, was conducted. 125 patients had cerebrovascular symptoms: either stroke (neurological deficit >24 h), Transient ischaemic attack (neurological deficit <24 h) or amaurosis fugax. Twelve patients were asymptomatic. A medical history and a fasting venous blood sample were taken from each patient around 6 weeks before surgery. The plasma concentrations of cholesterol and of inflammatory markers; (high sensitivity C-reactive protein (hs-CRP), sICAM-1, sVCAM-1, sE-selectin) were determined. Results: the concentration of hs-CRP in the symptomatic group (3.9 mg/L) was significantly higher than in the asymptomatic group (2.1 mg/L; p = 0.04). These concentrations were within normal range (<10 mg/L). sICAM-1, sVCAM-1, sE-selectin and total cholesterol concentrations were not different between the two groups. Conclusion: plasma hs-CRP was elevated in symptomatic compared to asymptomatic patients with carotid artery disease. High sensitivity C-reactive protein has been shown to be of prognostic value in a number of cardiovascular conditions and this study suggests it may be of value to identify patient at high risk of developing neurological deficits.
引用
收藏
页码:505 / 509
页数:5
相关论文
共 20 条
[1]   C-reactive protein (CRP) in cerebro-vascular events [J].
Canova, CR ;
Courtin, C ;
Reinhart, WH .
ATHEROSCLEROSIS, 1999, 147 (01) :49-53
[2]   RAISED C-REACTIVE PROTEIN-LEVELS IN SERUM FROM SMOKERS [J].
DAS, I .
CLINICA CHIMICA ACTA, 1985, 153 (01) :9-13
[3]   C-reactive protein in ischemic stroke - An independent prognostic factor [J].
Di Napoli, M ;
Papa, F ;
Bocola, V .
STROKE, 2001, 32 (04) :917-924
[4]   Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European carotid surgery trial (ECST) [J].
Farrell, B ;
Fraser, A ;
Sandercock, P ;
Slattery, J ;
Warlow, CP .
LANCET, 1998, 351 (9113) :1379-1387
[5]   Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly [J].
Harris, TB ;
Ferrucci, L ;
Tracy, RP ;
Corti, MC ;
Wacholder, S ;
Ettinger, WH ;
Heimovitz, H ;
Cohen, HJ ;
Wallace, R .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (05) :506-512
[6]   IMMUNOHISTOCHEMICAL LOCALIZATION OF C-REACTIVE PROTEIN-BINDING SITES IN HUMAN ATHEROSCLEROTIC AORTIC LESIONS BY A MODIFIED STREPTAVIDIN-BIOTIN-STAINING METHOD [J].
HATANAKA, K ;
LI, XA ;
MASUDA, K ;
YUTANI, C ;
YAMAMOTO, A .
PATHOLOGY INTERNATIONAL, 1995, 45 (09) :635-641
[7]  
Hwang SJ, 1997, CIRCULATION, V96, P4219
[8]   Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis [J].
Mocco, J ;
Choudhri, TF ;
Mack, WJ ;
Laufer, I ;
Lee, J ;
Kiss, S ;
Poisik, A ;
Quest, DO ;
Solomon, RA ;
Connolly, ES .
NEUROSURGERY, 2001, 48 (04) :718-721
[9]   C-reactive protein, inflammation, and coronary risk [J].
Morrow, DA ;
Ridker, PM .
MEDICAL CLINICS OF NORTH AMERICA, 2000, 84 (01) :149-+
[10]  
PEPYS MB, 1995, OXFORD TXB MED, P1527